[Retracted] Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer

Table 1

Comparison of baseline data between two groups.

Item		Sintilimab ()
Gender	Male	19
	Female	13
Age (years)
Body mass index (kg/m^2)
Complicated with diabetes		6
Complicated with hypertension		7
Tumor site	Uncinate process of pancreatic head	20
	Body and tail of pancreas	12
Nerve infiltration	Yes	14
	No	18
Degree of differentiation	Low/medium differentiation	19
	Highly differentiation	13